TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
GPCR

Structure Therapeutics Inc.

Healthcare · Biotechnology

35.10$ -2.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Structure Therapeutics Inc. (GPCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,425 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GPCR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
216 482 457 947 933 903 867 816 832 1,584 1,508 1,425
210 474 449 938 924 891 850 799 814 1,570 1,491 1,372
51 130 98 382 172 170 152 147 103 800 316 273
205 467 436 927 915 884 837 786 799 1,446 1,459 1,343
23 29 27 26 36 38 42 44 62 68 61 71
20 25 24 23 33 36 36 39 58 63 57 66
0.8 1.4 1.6 1.6 1.7 1.7 2.5 2.7 2.8 2.9 2.6 2.6
3.3 4.7 6.5 2.2 8.4 8.0 8.7 9.0 18 14 7.8 11
193 453 430 921 897 865 825 772 770 1,516 1,447 1,354
-182 -207 -233 -259 -293 -329 -376 -438 -503 -470 -546 -652
38 46 47 49 57 57 57 58 58 59 72 73

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?